ShandsKNSchminGPDanBB. Toxic shock syndrome in menstruating women: Association with tampon use and Staphylococcus aureus and clinical features in 52 casesN Engl J Med1980;303:1436–42
4.
JacobsonJAKaswormEMCrassBA. Nasal carriage of toxigenic Staphylococcus aureus and prevalence of serum antibody to toxic shock syndrome toxin 1 in UtahJ Infect Dis1986;153:356–9
5.
Centers for Disease Control update: Toxic shock syndrome—United States. MMWR1983;32:398–400
6.
ToddJKToddBHFranco-BuffA. Influence of focal growth conditions on the pathogenesis of toxic shock syndromeJ Infect Dis1981;155:613–81
7.
JacobsonJAStevensMHKaswormEM. Evaluation of single dose cefazolin prophylaxis for toxic shock syndromeArch Otolaryngol Head Neck Surg1988;114:326–1
8.
BredaSDJacobsJBLebowitzAS. Toxic shock syndrome in nasal surgery: A physiochemical and microbiologic evaluation of Merocel and Nugauze nasal packingLaryngoscope1981;97:1388–91
9.
YounisRTGrossCWLazarRH. Toxic shock syndrome following functional endonasal sinus surgery: A case reportHead Neck1991;13:247–8
10.
MoserNHoodCErvinD. Toxic shock syndrome in a patient using bilateral silicone nasal splintsOtolaryngol Head Neck Surg1995;113:632–3
11.
ToddJKRessmanMCastonS. Corticosteroid therapy for patients with toxic shock syndromeJAMA1984;252:3399–401
